Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma.

Br J Cancer · 2014 · PMC4102934 · PMID 24937669

Europe PMC DOI

hedged sentence

0.3530

closest p · 7.1× alpha

0.3530

boldest claim

The sentences

did not reach statistical significanceP =0.353not close (p > 0.1)

This trend, however, conflicted with a tendency to a higher rate of overall CR after cTACE at the same time point (58.1% vs 52.2%), due to the lower occurrence of new nodules in cTACE (5 out of 20, 25%) than in DEB-TACE patients (9 out of 23, 39%) at the time of progression, although this difference did not reach statistical significance ( P =0.353).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.